Search results
Results from the WOW.Com Content Network
DEA lawsuit NO. 20-71433, the Ninth Circuit dismissed a petition that asked the court to review the DEA's denial of a letter that requested the agency reschedule marijuana. Under the CSA, the DEA must begin investigating the rescheduling of a drug after receiving a petition by from any interested party, including the manufacturer of a drug, a ...
In a move that could significantly impact the cannabis reform landscape, the Drug Enforcement Administration (DEA) announced a delay on Monday in the rescheduling of marijuana, noting it would ...
Marijuana has been an illegal Schedule I drug since 1970, but re-scheduling it to be a Schedule III drug could have a limited effect on cannabis consumers, although some cannabis businesses have ...
Marijuana has been considered a Schedule I drug since the Controlled Substances Act was signed in 1970, falling into the same category as substances like heroin, MDMA or Ecstasy.
The Marijuana Opportunity Reinvestment and Expungement Act, also known as the MORE Act, is a proposed piece of U.S. federal legislation that would deschedule cannabis from the Controlled Substances Act and enact various criminal and social justice reforms related to cannabis, including the expungement of prior convictions.
For the $34 billion cannabis industry, the move would also eliminate significant tax burdens for businesses in states where the drug is legal, notably getting rid of the Internal Revenue Services ...
The United States Drug Enforcement Administration (DEA) maintains lists regarding the classification of illicit drugs (see DEA Schedules).It also maintains List I of chemicals and List II of chemicals, which contain chemicals that are used to manufacture the controlled substances/illicit drugs.
The federal government classified cannabis as a Schedule I drug in 1970. But how much of an impact would proposed changes have on laws? Marijuana laws could change as DEA considers reclassification